Methotrexate or expectant management in women with an ectopic pregnancy or pregnancy of unknown location and low serum hCG concentrations? A randomized comparison
Author(s) -
Norah M. van Mello,
Femke Mol,
Harold R Verhoeve,
Madelon van Wely,
Albert H. Adriaanse,
Erik A. Boss,
Antonius B Dijkman,
Neriman Bayram,
M.H. Emanuel,
Jaap Friederich,
Loes van der Leeuw-Harmsen,
J. P. Lips,
M.A. van Kessel,
W.M. Ankum,
Fulco van der Veen,
Ben W. Mol,
Petra J. Hajenius
Publication year - 2012
Publication title -
human reproduction
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.446
H-Index - 226
eISSN - 1460-2350
pISSN - 0268-1161
DOI - 10.1093/humrep/des373
Subject(s) - medicine , ectopic pregnancy , methotrexate , asymptomatic , pregnancy , randomization , obstetrics , gynecology , randomized controlled trial , expectant management , watchful waiting , regimen , gestation , genetics , prostate cancer , cancer , biology
What is the treatment success rate of systemic methotrexate (MTX) compared with expectant management in women with an ectopic pregnancy or a pregnancy of unknown location (PUL) with low and plateauing serum hCG concentrations?
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom